Prokidney reports second quarter financial results and recent corporate highlights

Winston-salem, n.c., aug. 10, 2023 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney” or the “company”), a leading late clinical-stage cellular therapeutics company focused on dialysis-free living for those with chronic kidney disease (ckd), today announced financial results for the second quarter ended june 30, 2023, and provided an update on recent corporate developments.
PROK Ratings Summary
PROK Quant Ranking